In so doing, they link the effects of olanzapine and NRG-1 deficiency-induced mitochondrial dysfunction to an NRG-1/miRNA-143-3p nexus that is associated with developmental pathobiology in schizophrenia and clinical response to antipsychotic drugs. The gene discussed is NRG1; the disease is schizophrenia.